Innovating eyecare for the 21st century
Iantech is working to invent and commercialize new surgical approaches which can reduce the global footprint of cataract induced visual impairment and blindness. Using smart efficient and adaptable microinterventional technology the company aims to catalyze global outreach efforts as we fight the 25M blindness epidemic in the world. Iantech was founded by ophthalmic surgeon innovator Dr. Sean Ianchulev Professor of Ophthalmology at New York Eye and Ear.
|Human health & social work||C Corporation||Operating||11 - 50 employees|
Funding and Financing Rounds
Jul 14, 2017
- Social Policies and Performance
Impact Reports & Metrics